1. Home
  2. EVH vs AURA Comparison

EVH vs AURA Comparison

Compare EVH & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$2.76

Market Cap

344.8M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.70

Market Cap

357.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
AURA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
357.5M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
EVH
AURA
Price
$2.76
$5.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
$10.67
$20.20
AVG Volume (30 Days)
3.2M
188.2K
Earning Date
02-24-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,054,052,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$26.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.56
$4.35
52 Week High
$12.07
$8.16

Technical Indicators

Market Signals
Indicator
EVH
AURA
Relative Strength Index (RSI) 28.46 49.76
Support Level $2.56 $5.26
Resistance Level $2.91 $5.82
Average True Range (ATR) 0.20 0.32
MACD -0.03 0.00
Stochastic Oscillator 21.08 34.83

Price Performance

Historical Comparison
EVH
AURA

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: